Our Chief Scientific Officer Jonathan O’Halloran recently contributed to the Review on Antimicrobial Resistance report published last Friday.
The review, led by Jim O’Neill, sets out proposals to transform antibiotic use through better use of rapid diagnostics over the next 5 years. This is the latest in a series of reports by the Review on AMR, before their final recommendations setting out a global package of actions in the late Spring of 2016.
Jonathan commented “It is incredibly gratifying to see such emphasis being placed upon the pivotal role of diagnostics in tackling the threat of AMR. With microbes becoming ever more sophisticated in evading our arsenal of anti-infectives, we must become more sophisticated in our diagnosis and surveillance. There isn’t a doctor on the planet that can determine whether an infection will be resistant to a certain therapy by simply relying on an empirical diagnosis. Now is the time to invest in technologies such as AI and Advanced Rapid Diagnostics to provide our doctors with the tools required to prescribe the right drug at the right time.”